GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Par Drugs and Chemicals PAR.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

113.17

+3.83%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹1.04bn

FY2017FY2026

Net income

₹131.1m

FY2017FY2026

Free cash flow

₹144.7m

FY2017FY2026

Shareholders' equity

₹1.12bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹1.04bn₹1.01bn₹956.4m₹951.0m₹746.1m₹598.8m₹551.0m₹456.0m₹420.3m₹467.2m
Research and development—₹1.8m₹1.1m₹1.0m₹147,415₹988,000₹666,394₹543,214₹225,372—
Operating income₹174.3m₹161.1m₹201.6m₹152.1m₹130.8m₹153.7m₹66.3m₹51.7m₹48.5m₹56.4m
Net income₹131.1m₹133.6m₹145.0m₹113.3m₹92.1m₹116.1m₹47.6m₹25.1m₹15.0m₹18.5m
Diluted earnings per share10.6510.8611.799.217.499.443.872.041.191.50

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹1.29bn₹1.19bn₹1.02bn₹888.7m₹786.9m₹763.8m₹601.2m₹513.6m₹539.4m₹560.4m
Cash and short-term investments₹418.4m₹275.8m₹366.5m₹222.4m₹162.1m₹211.6m₹73.8m₹306,000₹637,000₹184,000
Total liabilities₹172.3m₹204.2m₹159.8m₹176.3m₹188.1m₹241.7m₹195.0m₹222.4m₹332.4m₹368.4m
Debt——−₹51,000₹623,000₹90,000₹83.2m₹60.1m₹115.8m₹231.3m₹248.1m
Shareholders' equity₹1.12bn₹989.7m₹856.3m₹712.4m₹598.8m₹522.1m₹406.1m₹291.2m₹207.0m₹192.0m
Shares outstanding12m12m12m12m12m12m12m12m13m12m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹164.3m₹161.6m₹202.5m₹133.8m₹76.2m₹120.9m₹76.9m₹75.8m₹43.2m₹91.7m
Capital spending−₹19.6m−₹12.3m−₹60.8m−₹76.3m−₹32.0m−₹50.5m−₹15.6m−₹3.4m−₹6.4m−₹18.1m
Free cash flow₹144.7m₹149.3m₹141.7m₹57.4m₹44.1m₹70.4m₹61.3m₹72.3m₹36.8m₹73.6m
Dividends paid————−₹15.4m−₹7.7m−₹7.7m−₹668−₹575−₹1,000

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹312.8m₹196.1m₹293.4m₹286.6m₹260.5m₹223.3m₹213.8m₹346.6m
Operating income₹54.2m₹5.1m₹51.3m₹51.3m₹26.6m₹15.1m₹5.1m₹105.0m
Net income₹47.1m₹8.5m₹48.0m₹41.3m₹33.3m₹16.5m₹5.8m₹86.0m
Diluted earnings per share3.830.693.903.362.701.340.476.99
Cash from operations———₹80.0m————
Capital spending———−₹7.0m————
Free cash flow———₹73.0m————
Total assets—₹1.29bn—₹1.28bn—₹1.19bn—₹1.16bn
Cash and short-term investments₹418.4m₹418.4m₹338.6m₹338.6m₹275.8m₹275.8m₹187.8m₹187.8m
Shareholders' equity₹1.12bn₹1.12bn₹1.06bn₹1.06bn₹989.7m₹989.7m₹967.6m₹967.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.9%11.6%12.0%
Operating income4.6%2.5%14.4%
Net income5.0%2.5%41.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin16.4%17.4%18.4%16.5%
Net margin12.9%13.2%13.8%11.2%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings10.09.416.923.419.921.49.410.8
Price to sales1.31.22.62.82.54.20.80.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 22 Nov 2021.

FY2022FY2021FY2020
Paid in the year1.250.6250.625
  • 2-for-1 split · 27 Apr 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.